CHRONIC CLOZAPINE VERSUS CHRONIC HALOPERIDOL TREATMENT - DIFFERENTIAL-EFFECTS ON ELECTRICALLY-EVOKED DOPAMINE EFFLUX IN THE RAT CAUDATE-PUTAMEN, BUT NOT IN THE NUCLEUS-ACCUMBENS
Kj. Feaseytruger et al., CHRONIC CLOZAPINE VERSUS CHRONIC HALOPERIDOL TREATMENT - DIFFERENTIAL-EFFECTS ON ELECTRICALLY-EVOKED DOPAMINE EFFLUX IN THE RAT CAUDATE-PUTAMEN, BUT NOT IN THE NUCLEUS-ACCUMBENS, Naunyn-Schmiedeberg's archives of pharmacology, 354(6), 1996, pp. 725-730
Fast cyclic voltammetry at carbon-fibre microelectrodes was used to in
vestigate the effects of chronic clozapine or haloperidol administrati
on on electrically evoked dopamine efflux in the nucleus accumbens and
caudate putamen of the anaesthetized rat. Stimulation trains were del
ivered to the median forebrain bundle (60 pulses, 350 mu s duration) e
very 5 min, and the evoked dopamine efflux measured as a function of a
) the applied stimulus intensity (range 0.2 mA-1.0 mA), and b) the app
lied stimulus frequency (range 10 Hz-250 Hz). Chronic administration o
f either clozapine (20 mg/kg x 21 days, p.o.) or haloperidol (1 mg/kg
x 21 days, p.o.) significantly reduced electrically evoked dopamine ef
flux in the nucleus accumbens over the range of stimulus intensities a
nd frequencies tested. The reduction in evoked dopamine efflux observe
d in the nucleus accumbens of clozapine- and haloperidol-treated rats
showed no statistically significant difference. In contrast, only chro
nic haloperidol treatment significantly reduced evoked dopamine efflux
in the caudate putamen. These findings demonstrate that chronic treat
ment with either the atypical neuroleptic, clozapine, or the typical n
euroleptic, haloperidol, produce long-term changes in mesolimbic dopam
ine function; actions which may underlie their antipsychotic efficacy.
They also provide further evidence that the sparing action of clozapi
ne on nigrostriatal dopamine activity may underlie the lower incidence
of extrapyramidal side effects associated with its long-term administ
ration.